News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
The US Food and Drug Administration will require all new vaccines go through placebo-controlled studies before they are ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
1d
MedPage Today on MSNFDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other VaccinesThe unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
The U.S. FDA is planning to require all new vaccines to undergo placebo-controlled trials before approval. Read more here.
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.
As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...
The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...
Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine after the agency grants full approval. The company said it had responded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results